Monitoring Agency Report issued by CRISIL Ratings Limited for monitoring the utilization of funds raised through Qualified Institutional Placement as approved by the Board and members of the Company in their respective meetings held on September 04, 2025 and September 29, 2025, for the quarter ended on March 31, 2026.
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CRISIL Ratings Limited has issued its monitoring agency report for Zota Health Care's Qualified Institutional Placement (QIP) for the quarter ended March 31, 2026. The QIP was conducted from December 15-17, 2025, raising Rs 34,033.24 lakh (net proceeds). During this quarter, the company has NOT deployed any funds towards the stated objects of the issue - all proceeds remain unutilized and are parked in Fixed Deposits with ICICI Bank. The planned utilization includes working capital (Rs 13,537.49 lakh), investment in DHML for COCO stores (Rs 12,962.50 lakh), and general corporate purposes (Rs 7,533.25 lakh). The monitoring agency confirms no deviations from disclosed objects, no changes in means of finance, and no material concerns. The company states funds will be utilized in a phased manner as per the Placement Document.
The filing is routine and compliance-based. Zero utilization is not a concern as the company has stated a phased deployment plan. Shareholders can expect fund deployment to begin post-April 1, 2026. The Rs 34,033.24 lakh is safely parked in ICICI Bank FDs earning interest (Rs 469.63 lakh earned).